CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancer.

In our cohort, the CD57 + CD8 + T cells to total T cells ratio was the only parameter that showed significant predictive value, while other clinicopathological parameters, including CD8 + T cells to total T cells ratio and PD-L1 positivity, did not reach statistical significance (Table 3 ).

also in 111,027 other papers